🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to our graduating IC fellows Adam Hafeez, Morgan Randall, Nate Gargus. We are proud of you and excited about what you do! UF Health Ki Park

Great talks by colleagues Dr Shuja/Sheehan/Robinson/Wyers. UF Surgery Mayo Clinic Vascular and Endovascular Surgery BIDMC Department of Surgery Wake Forest University Vascular Surgery

Congratulations!! We are proud of you!

nytimes.com/2023/07/15/hea… Would encourage all patients with PAD to get a second opinion from vascular specialists who work in multidisciplinary teams and minimize conflict of interest.

“Culture that values research” is key. So many obstacles it feels like an uphill battle many days and requires a particularly motivated PI.

📖Veteran pts w obstructive #CAD have worse overall prognosis after #TAVR, although #PCI prior to #TAVR does not improve outcomes. ➡️doi.org/10.1016/j.jsca… Khanjan Shah Dhruv Mahtta StephenWaldoMD Ali Denktas Umair Khalid

This was a labor of love. I hope it helps others on the path. ⁦Samantha Minc MD MPH⁩ ⁦Caitlin Hicks MD, MS⁩ ⁦Andrea Obi MD⁩ ⁦MUSC Vascular Surgery⁩ ⁦TzeWoeiTan, MBBS, MPH, FACS⁩ ⁦tammytnguyen⁩ ⁦Nick Osborne⁩ ⁦Maryland Surgery⁩ ⁦UF Vascular⁩ jvsvi.org/article/S2949-…

A real treat to have William W. O'Neill visit UF Health to discuss his legacy of improving the lives of patients with AMI/CS.

🆕📑Presented at #ACC24 💡TAVR is the predominant modality of all AVR for isolated severe AS including pts <65 years old. #TAVR #SAVR #Guidelines #JSCAI Read the findings today: ➡️ doi.org/10.1016/j.jsca… Tanush Gupta Harold Dauerman James T. DeVries, MD fahad gilani

We are not crazy after all

Positive trial for Impella-CP in AMI/CS! Especially important in centers resistant to change. Congratulations to the investigators on a job well done!

After years in the wilderness following RCT results they just weren't expecting, for example BARI 2 COURAGE ISCHEMIA REVIVED-BCIS2 TASTE TOTAL It's great to see my IC friends' unbridled joy (or is it relief?!) at the results of DanGer Shock! 😆 #ACC2024 #cardiotwitter

The PREVENT trial showed that preventive #PCI of focal non-FFR-positive plaques that are angiographically >50% & have evidence of vulnerability on intravascular imaging along w/ OMT is superior to OMT for clinical outcomes at 2 years. Read more: bit.ly/3xuHWrl #ACC24

Very much enjoyed visiting UR Medicine and meet with faculty and fellows to share our work. Thanks for a great trip!

Wishing you the best Ki Park! We will miss you ❤️

Enjoyed working 'across the aisle' with my vascular surgery colleagues on this secondary analysis of BEST-CLI. Bottom line: our youngest patient with CLTI are the most vulnerable to amputations overall but may derive more benefit from a bypass first strategy.

Honored to be visiting professor McGill Vascular today. Nice discussion about alternative vascular access with an accomplished group of faculty and trainees. Thank you! UF Surgery

My 6yo seems to have cracked my code

This is very helpful in discussing expectations & prognosis with patients and their families CHIP carries a high in-hospital mortality..We need a cultural change or these patients will not get a fighting chance to survive due to risk aversion

I'm thrilled to announce that we've completed randomizing 1252 pts with LVEF <40% and complex CAD to high-risk PCI with Impella CP support vs. control. Now we are in the 1-year follow-up phase and then the results of the PROTECT IV trial will be reported.